Aurenix Biosciences is the spinout translating MeTS from bench to platform, co-founded with Andrea Balukova. Work so far has included ICURe customer discovery, proposals to translational partners, and early-stage grant funding through routes including BBSRC and the Marie Skłodowska-Curie scheme.

Auxii Inc is the holding company behind Aurenix and my other ventures — also home to Grantalyze, an AI-assisted grant-writing tool I prototyped, complete with a pitch deck and investor demo.

More to come as the work develops.